(Q43441466)

English

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection

scientific article published on 20 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

sodium stibogluconate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Koert Ritmeijer

1

object named as

Koert Ritmeijer

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Abren Dejenie

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Yibeltal Assefa

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Tadesse Beyene Hundie

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Jo Mesure

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Gerry Boots

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Margriet den Boer

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Robert N Davidson

8

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

20 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

357-364

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Visceral leishmaniasis and HIV in Tigray, Ethiopia

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Visceral leishmaniasis in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Trial of oral miltefosine for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Oral miltefosine for Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

A policy for leishmaniasis with respect to the prevention and control of drug resistance

1 reference

https://api.crossref.org/works/10.1086%2F505217

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43441466&oldid=1988893994"